⌘K
Loading ticker…
As of 2026-08-24, Mereo BioPharma Group plc American Depositary Shares (MREO) has a 3-month relative strength percentile of 56 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 36. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 9.2%, relative volume 0.08×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
MREO is in a stage 4 downtrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -6.7% / -54.9%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
MREO is held by 2 ETFs as of Apr 2026. Top owner: IDNA at 0.04% weight, $62K notional.
Held by 3 ETFs · $141K across latest filings · largest weight 0.09% (BBC).
Top 2 by value, from SEC N-PORT-P filings dated Apr 2026.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MREO Jan avg: 20.09% median: 15.14% win: 75% σ: 33.30% n: 4 2022-04-12 → 2026-07-31 | MREO Feb avg: -10.08% median: -10.17% win: 25% σ: 9.55% n: 4 2022-04-12 → 2026-07-31 | MREO Mar avg: -12.79% median: -12.06% win: 0% σ: 6.06% n: 4 2022-04-12 → 2026-07-31 | MREO Apr avg: 8.22% median: -7.58% win: 40% σ: 46.55% n: 5 2022-04-12 → 2026-07-31 | MREO May avg: -3.42% median: -16.99% win: 40% σ: 22.70% n: 5 2022-04-12 → 2026-07-31 | MREO Jun avg: 35.01% median: 26.05% win: 80% σ: 50.89% n: 5 2022-04-12 → 2026-07-31 | MREO Jul avg: -1.64% median: 7.87% win: 80% σ: 20.58% n: 5 2022-04-12 → 2026-07-31 | MREO Aug avg: 4.72% median: 2.10% win: 75% σ: 7.37% n: 4 2022-04-12 → 2026-07-31 (current) | MREO Sep avg: -6.49% median: -9.10% win: 25% σ: 20.29% n: 4 2022-04-12 → 2026-07-31 | MREO Oct avg: 16.55% median: 9.28% win: 75% σ: 27.70% n: 4 2022-04-12 → 2026-07-31 | MREO Nov avg: -8.22% median: -7.98% win: 25% σ: 11.62% n: 4 2022-04-12 → 2026-07-31 | MREO Dec avg: -18.73% median: -3.87% win: 25% σ: 39.91% n: 4 2022-04-12 → 2026-07-31 |